Oxford Asset Management’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q1
Sell
-30,219
Closed -$1.57M 279
2019
Q4
$1.57M Sell
30,219
-15,498
-34% -$804K 0.04% 571
2019
Q3
$2.51M Sell
45,717
-71,355
-61% -$3.92M 0.06% 413
2019
Q2
$4.76M Buy
117,072
+55,407
+90% +$2.25M 0.1% 247
2019
Q1
$1.87M Sell
61,665
-21,172
-26% -$640K 0.04% 613
2018
Q4
$2.78M Buy
82,837
+24,656
+42% +$829K 0.07% 321
2018
Q3
$2.44M Buy
+58,181
New +$2.44M 0.05% 546
2018
Q2
Sell
-27,050
Closed -$1.35M 1685
2018
Q1
$1.35M Sell
27,050
-9,570
-26% -$476K 0.03% 783
2017
Q4
$1.96M Buy
36,620
+4,048
+12% +$216K 0.04% 586
2017
Q3
$1.9M Sell
32,572
-1,793
-5% -$104K 0.04% 645
2017
Q2
$1.7M Sell
34,365
-25,651
-43% -$1.27M 0.03% 682
2017
Q1
$2.61M Buy
60,016
+1,242
+2% +$54K 0.06% 340
2016
Q4
$2.88M Sell
58,774
-29,035
-33% -$1.42M 0.1% 204
2016
Q3
$4.2M Buy
87,809
+4,179
+5% +$200K 0.13% 181
2016
Q2
$4.49M Sell
83,630
-21,415
-20% -$1.15M 0.15% 166
2016
Q1
$4.7M Buy
105,045
+14,230
+16% +$636K 0.13% 173
2015
Q4
$3.53M Buy
90,815
+49,771
+121% +$1.93M 0.08% 270
2015
Q3
$1.31M Sell
41,044
-45
-0.1% -$1.43K 0.04% 357
2015
Q2
$1.36M Sell
41,089
-19,584
-32% -$647K 0.04% 409
2015
Q1
$2.5M Sell
60,673
-85,858
-59% -$3.53M 0.06% 319
2014
Q4
$5.99M Buy
146,531
+63,945
+77% +$2.61M 0.13% 161
2014
Q3
$3.1M Buy
+82,586
New +$3.1M 0.07% 283
2014
Q2
Sell
-108,953
Closed -$4.48M 688
2014
Q1
$4.48M Buy
108,953
+18,038
+20% +$741K 0.13% 239
2013
Q4
$3.47M Sell
90,915
-31,865
-26% -$1.22M 0.09% 317
2013
Q3
$2.94M Buy
122,780
+111,085
+950% +$2.66M 0.07% 357
2013
Q2
$199K Buy
+11,695
New +$199K 0.01% 794